Description
Bacteriostatic water (bac water) is sold separately.
Potential Benefits — Research Is Ongoing
Potential benefits are based mainly on cell and animal studies; benefits from administering MOTS-C to humans remain unconfirmed.
- Exercise capacity: May support greater endurance and physical performance.
- Insulin sensitivity: May help tissues respond more effectively to insulin.
- Muscle glucose use: May support the use of glucose by skeletal muscle.
- Metabolic flexibility: May help cells adapt their energy handling to metabolic demands.
- Resistance to fat accumulation: May help limit diet-related fat accumulation.
- Cellular stress resilience: May support metabolic responses that help cells cope with stress.
Research sources: Metabolic-homeostasis study; Exercise and performance study.
Research Overview
Mitochondrial-derived peptide investigated in cellular energy and metabolic signalling research.
Mechanism / Pathway
MOTS-c is studied as a mitochondrial-derived signalling peptide. Experimental work links its activity with metabolic stress responses and AMPK-associated pathways; the effect depends on the model and exposure conditions.
Published Research
Scientific Profile
- Identity: MOTS-c / mitochondrial open reading frame of the 12S rRNA-c
- Structural class: Mitochondrial-derived 16-amino-acid peptide
- Research context: Cellular metabolic signalling and mouse experiments
- Product limitation: The labelled 20 mg amount does not establish a tested human exposure or concentration
Research Areas
- Mitochondrial-to-cellular signalling
- Insulin-sensitivity models
- Metabolic stress responses and translation from animal research
MOTS-C 20 mg Vial
MOTS-C, supplied as lyophilised powder in a B&A Premium vial with a holographic product label.
About this vial presentation
MOTS-C 20 mg Vial is supplied as one vial in the B&A Premium range. The labelled amount of 20 mg refers to the total contents of the vial, rather than a dose or liquid volume. Use the actual batch label to confirm identity, total dry content, storage and expiry information. This vial is supplied as lyophilised powder, not as a liquid or ready-made solution.
Browse the vial collection to compare product names, quantities and formats. Bacteriostatic water is sold separately; this does not establish that it is compatible with this formulation. For documentation relating to MOTS-C 20 mg Vial, contact B&A Premium with the batch reference.
Product details
- Contents: MOTS-C
- Labelled amount per vial: 20 mg
- Presentation: lyophilised powder in a vial
- Pack: 1 vial
Storage
Keep refrigerated at 2–8°C and protected from light. Follow the batch label for expiry and handling instructions.
Important research information
For research use only. The labelled amount is the total content per vial, not a dose. Product artwork is illustrative; consult the supplied label for batch-specific details.
Looking for another presentation? View the MOTS-C 20 mg prefilled pen. Compare each listing’s format and labelled contents; vial powder and prefilled pens are separate presentations.
Warnings, Contraindications & Safety Information
Research use only. This is an evidence-limited safety summary, not a package insert, complete prescribing information or permission for self-administration. References to licensed medicines describe those specific products; they do not establish B&A product approval, equivalence or safety.
Contraindications & Who Should Avoid Exposure
A clinically validated contraindication list for this exact research presentation has not been established. That absence is not evidence of safety. Do not expose a person with a known allergy to a labelled ingredient or excipient.
Warnings & Precautions
This research presentation has not been established as safe for human administration. Do not use during pregnancy or breastfeeding, or in children. A serious medical condition, including cancer or significant liver or kidney disease, requires professional assessment; this page cannot establish suitability.
Possible Adverse Reactions
Reliable frequencies and a complete human adverse-reaction profile for this exact product are unavailable. Allergy, local irritation and contamination-related harm remain possible; absence of reports does not establish absence of risk.
Drug & Supplement Interactions
Drug and supplement interactions have not been adequately characterised for this presentation. Do not assume that combining it with prescription medicines, hormones or other research compounds is safe. Give a clinician the full ingredient list if exposure has occurred.
When to Seek Urgent Help
Seek emergency care for difficulty breathing, swelling of the face or throat, collapse, severe persistent abdominal pain, or repeated vomiting with inability to keep fluids down. Stop further exposure and show the clinician the product label and ingredient list.
Handling & Storage Cautions
Follow the actual product label and batch-specific expiry information. Do not use damaged, contaminated or unexpectedly changed material. Powder appearance, refrigeration or addition of bacteriostatic water does not prove sterility, compatibility or a safe shelf life. Do not share needles, pens or opened material between people.
Safety references: FDA research-peptide and compounding safety context. Information reviewed 20 October 2026.
Reviews
There are no reviews yet.